High IL-18 levels were detected in patients with gastrointestinal disease (130), breast cancers (131), and in multiple myeloma (132); NLRC4 overexpression or high IL-18 levels contributed to a poor prognosis in gliomas (133) and acute myeloid leukemia (134). This evidence concerns the gene IL18 and glioma.